Advancements in diagnosis, management & treatment have significantly improved diabetes care, offering more precise and individualized approaches. Early diagnosis relies on fasting glucose, HbA1c levels, and continuous glucose monitoring, enabling timely intervention. Management strategies incorporate a combination of pharmacological treatments, lifestyle modifications, and emerging digital health technologies. While metformin remains a first-line therapy, newer agents such as GLP-1 receptor agonists and SGLT2 inhibitors provide cardiovascular and renal benefits beyond glycemic control. Insulin therapy continues to evolve, with ultra-long-acting formulations improving adherence. Personalized treatment plans integrating dietary counseling, physical activity, and behavioral support ensure optimal outcomes, while telemedicine and wearable devices enhance patient monitoring and engagement in diabetes self-care.










Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : An intelligent hierarchical medical platform established upon high-quality datasets improves the effectiveness of glycemic management for patients across different levels of hospitals
Zhiheng Zhou, Southern Medical University
Title : Diabetes pathogenesis and prevention
Madhu S Malo, Stapgen LLC
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Differential diagnosis of diabetes in young and prevalence of LADA and LADY in young persons attending tertiary diabetes institute in Bengaluru, India
R Anil Kumar, Karnataka Institute of Endocrinology and Research
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Endocrine-specific diabetes risk modeling, glucose–insulin dynamics, and simulation-based metabolic review using the BVidAL clinical software suite
Abhishek Bansal, New Era Consultancy Services
Title : Using a multi-disciplinary clinic model to prevent diabetic foot ulcer recurrence
Kaishi Yang, Albert Einstein College of Medicine
Title : Shaping the future of diabetes care: New advancements in treatment, digital health and personalized patient care
Rupesh K Gautam, Amity Institute of Pharmacy